Atlas Trials

LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients

Clinical trial NCT02077257 · UNKNOWN

Trial details

NCT number
NCT02077257
Sponsor
Committee of Cardio-Cerebral-Vascular Diseases of GSC
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Coronary Syndrome
Start date
2014-03-01
Primary completion
2015-12-01
Enrollment
1060

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.